Determination by asymmetric total synthesis of the absolute configuration of lucilactaene, a cell-cycle inhibitor in p53-transfected cancer cells

Angew Chem Int Ed Engl. 2005 May 13;44(20):3110-5. doi: 10.1002/anie.200500060.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Biomimetics
  • Cell Cycle / drug effects
  • Furans / chemical synthesis*
  • Furans / chemistry*
  • Furans / pharmacology
  • Fusarium / chemistry
  • Molecular Conformation
  • Molecular Structure
  • Optical Rotation
  • Pyrroles / chemical synthesis*
  • Pyrroles / chemistry*
  • Pyrroles / pharmacology
  • Stereoisomerism
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Antineoplastic Agents
  • Furans
  • Pyrroles
  • Tumor Suppressor Protein p53
  • lucilactaene